Additional European Equity News

ASML (ASML NA) - CFO says in H2 an improvement will be seen in the service business, and EUV tools out of warranty. Working with supply chain and customers to make sure tariffs impact are as limited as possible. Tariffs are still very uncertain. (Newswires)

AstraZeneca (AZN LN) - CARES Phase III clinical programme of anselamimab in light chain amyloidosis did not meet primary endpoint. Evaluation of results are ongoing. (Newswires) 

Ceconomy (CEC GY) - 9M (EUR): Adj EBIT 258mln. Q3: Sales growth adj. for currency and portfolio effects +5%. Guidance: FY Adj. EBIT 375mln. (Newswires) 

Sobi (SOBI SS) - Q2 (SEK): EBIT 1.01bln (exp. 1.02bln), Revenue 6.17bln (exp. 6.18bln). (Newswires) 

Stellantis (STLAM IM/STLAP FP) - Discontinues hydrogen fuel cell technology development programme; in discussions for alternatives. Has no staffing impact at production sites. (Newswires) 

TotalEnergies (TTE FP) - Q2 Trading Update: European Refining Market Market USD 35.3/t (prev. USD 29.4/t Q/Q). Integrated LNG results exp. to reflect better environment conditions Y/Y. Refining and Chemicals exp. to be in same range as 2024. (Newswires)